Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide.

JCI insight

Kanakry CG, Coffey DG, Towlerton AM, Vulic A, Storer BE, Chou J, Yeung CC, Gocke CD, Robins HS, O'Donnell PV, Luznik L, Warren EH.
PMID: 27213183
JCI Insight. 2016;1(5). doi: 10.1172/jci.insight.86252. Epub 2016 Apr 21.

Posttransplantation cyclophosphamide (PTCy) effectively prevents graft-versus-host disease (GVHD), but its immunologic impact is poorly understood. We assessed lymphocyte reconstitution via flow cytometry (

Cite
Kanakry CG, Coffey DG, Towlerton AM, et al. Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide. JCI Insight. 2016;1(5)doi: 10.1172/jci.insight.86252.
Kanakry, C. G., Coffey, D. G., Towlerton, A. M., Vulic, A., Storer, B. E., Chou, J., Yeung, C. C., Gocke, C. D., Robins, H. S., O'Donnell, P. V., Luznik, L., & Warren, E. H. (2016). Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide. JCI insight, 1(5), . https://doi.org/10.1172/jci.insight.86252
Kanakry, Christopher G, et al. "Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide." JCI insight vol. 1,5 (2016). doi: https://doi.org/10.1172/jci.insight.86252
Kanakry CG, Coffey DG, Towlerton AM, Vulic A, Storer BE, Chou J, Yeung CC, Gocke CD, Robins HS, O'Donnell PV, Luznik L, Warren EH. Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide. JCI Insight. 2016;1(5). doi: 10.1172/jci.insight.86252. Epub 2016 Apr 21. PMID: 27213183; PMCID: PMC4874509.
Copy Download .nbib Format: NLM
Therapeutic dilemma in the management of a patient with the clinical picture of TTP and severe B12 deficiency.

BMC hematology

Walter K, Vaughn J, Martin D.
PMID: 26634125
BMC Hematol. 2015 Dec 01;15:16. doi: 10.1186/s12878-015-0036-2. eCollection 2015.

BACKGROUND: Idiopathic thrombotic thrombocytopenic purpura (TTP) is a rare hematological emergency characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia, neurological symptoms, renal injury, and fever that is invariably fatal if left untreated. Prompt intervention with plasma exchange minimizes...

Cite
Walter K, Vaughn J, Martin D. Therapeutic dilemma in the management of a patient with the clinical picture of TTP and severe B12 deficiency. BMC Hematol. 2015;15:16doi: 10.1186/s12878-015-0036-2.
Walter, K., Vaughn, J., & Martin, D. (2015). Therapeutic dilemma in the management of a patient with the clinical picture of TTP and severe B12 deficiency. BMC hematology, 1516. https://doi.org/10.1186/s12878-015-0036-2
Walter, Kara, et al. "Therapeutic dilemma in the management of a patient with the clinical picture of TTP and severe B12 deficiency." BMC hematology vol. 15 (2015): 16. doi: https://doi.org/10.1186/s12878-015-0036-2
Walter K, Vaughn J, Martin D. Therapeutic dilemma in the management of a patient with the clinical picture of TTP and severe B12 deficiency. BMC Hematol. 2015 Dec 01;15:16. doi: 10.1186/s12878-015-0036-2. eCollection 2015. PMID: 26634125; PMCID: PMC4667528.
Copy Download .nbib Format: NLM
Hematopoietic Cell Transplantation for Older Patients with MDS.

Mediterranean journal of hematology and infectious diseases

Shadman M, Deeg HJ.
PMID: 25237469
Mediterr J Hematol Infect Dis. 2014 Sep 01;6(1):e2014056. doi: 10.4084/MJHID.2014.056. eCollection 2014.

The incidence of myeloid malignancies, including myelodysplastic syndromes (MDS) increases with age. While several therapeutic modalities have been developed, for most of these patients the only treatment with curative potential is allogeneic hematopoietic cell transplantation (HCT). The development of...

Cite
Shadman M, Deeg HJ. Hematopoietic Cell Transplantation for Older Patients with MDS. Mediterr J Hematol Infect Dis. 2014;6(1):e2014056doi: 10.4084/MJHID.2014.056.
Shadman, M., & Deeg, H. J. (2014). Hematopoietic Cell Transplantation for Older Patients with MDS. Mediterranean journal of hematology and infectious diseases, 6(1), e2014056. https://doi.org/10.4084/MJHID.2014.056
Shadman, Mazyar, and Deeg, H Joachim. "Hematopoietic Cell Transplantation for Older Patients with MDS." Mediterranean journal of hematology and infectious diseases vol. 6,1 (2014): e2014056. doi: https://doi.org/10.4084/MJHID.2014.056
Shadman M, Deeg HJ. Hematopoietic Cell Transplantation for Older Patients with MDS. Mediterr J Hematol Infect Dis. 2014 Sep 01;6(1):e2014056. doi: 10.4084/MJHID.2014.056. eCollection 2014. PMID: 25237469; PMCID: PMC4165501.
Copy Download .nbib Format: NLM
Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature.

Experimental hematology & oncology

Roberts TK, Chen X, Liao JJ.
PMID: 27127726
Exp Hematol Oncol. 2016 Apr 27;5:13. doi: 10.1186/s40164-016-0042-5. eCollection 2015.

BACKGROUND: Epstein-Barr virus-positive mucocutaneous ulcer (EBVMCU) is a recently recognized B cell lymphoproliferative disorder that is driven by latent EBV infection and causes discrete ulcerations in the oropharynx, gastrointestinal tract, and skin. Local attenuation of immunosurveillance associated with iatrogenic...

Cite
Roberts TK, Chen X, Liao JJ. Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature. Exp Hematol Oncol. 2016;5:13doi: 10.1186/s40164-016-0042-5.
Roberts, T. K., Chen, X., & Liao, J. J. (2015). Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature. Experimental hematology & oncology, 513. https://doi.org/10.1186/s40164-016-0042-5
Roberts, Toni K, et al. "Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature." Experimental hematology & oncology vol. 5 (2015): 13. doi: https://doi.org/10.1186/s40164-016-0042-5
Roberts TK, Chen X, Liao JJ. Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature. Exp Hematol Oncol. 2016 Apr 27;5:13. doi: 10.1186/s40164-016-0042-5. eCollection 2015. PMID: 27127726; PMCID: PMC4848873.
Copy Download .nbib Format: NLM
Managing thrombosis in cancer patients.

Research and practice in thrombosis and haemostasis

Wang TF, Li A, Garcia D.
PMID: 30046747
Res Pract Thromb Haemost. 2018 May 01;2(3):429-438. doi: 10.1002/rth2.12102. eCollection 2018 Jul.

Venous thromboembolism is a major complication in cancer patients. The basis for the strong association between cancer and thrombosis remains incompletely understood, and the optimal approaches to both the treatment and the prevention of cancer-associated thrombosis are evolving. Here...

Cite
Wang TF, Li A, Garcia D. Managing thrombosis in cancer patients. Res Pract Thromb Haemost. 2018;2(3):429-438doi: 10.1002/rth2.12102.
Wang, T. F., Li, A., & Garcia, D. (2018). Managing thrombosis in cancer patients. Research and practice in thrombosis and haemostasis, 2(3), 429-438. https://doi.org/10.1002/rth2.12102
Wang, Tzu-Fei, et al. "Managing thrombosis in cancer patients." Research and practice in thrombosis and haemostasis vol. 2,3 (2018): 429-438. doi: https://doi.org/10.1002/rth2.12102
Wang TF, Li A, Garcia D. Managing thrombosis in cancer patients. Res Pract Thromb Haemost. 2018 May 01;2(3):429-438. doi: 10.1002/rth2.12102. eCollection 2018 Jul. PMID: 30046747; PMCID: PMC6046582.
Copy Download .nbib Format: NLM
Platelet trends after Covid-19 vaccination in patients with chronic or persistent immune thrombocytopenia.

American journal of hematology

Jiang D, Portuguese AJ, Weatherford A, Garcia D, Gernsheimer T.
PMID: 34619804
Am J Hematol. 2021 Dec 01;96(12):E472-E474. doi: 10.1002/ajh.26366. Epub 2021 Oct 19.

No abstract available.

Cite
Jiang D, Portuguese AJ, Weatherford A, et al. Platelet trends after Covid-19 vaccination in patients with chronic or persistent immune thrombocytopenia. Am J Hematol. 2021;96(12):E472-E474doi: 10.1002/ajh.26366.
Jiang, D., Portuguese, A. J., Weatherford, A., Garcia, D., & Gernsheimer, T. (2021). Platelet trends after Covid-19 vaccination in patients with chronic or persistent immune thrombocytopenia. American journal of hematology, 96(12), E472-E474. https://doi.org/10.1002/ajh.26366
Jiang, Debbie, et al. "Platelet trends after Covid-19 vaccination in patients with chronic or persistent immune thrombocytopenia." American journal of hematology vol. 96,12 (2021): E472-E474. doi: https://doi.org/10.1002/ajh.26366
Jiang D, Portuguese AJ, Weatherford A, Garcia D, Gernsheimer T. Platelet trends after Covid-19 vaccination in patients with chronic or persistent immune thrombocytopenia. Am J Hematol. 2021 Dec 01;96(12):E472-E474. doi: 10.1002/ajh.26366. Epub 2021 Oct 19. PMID: 34619804; PMCID: PMC8616807.
Copy Download .nbib Format: NLM
Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin.

Bone marrow transplantation

Yeh AC, O'Donnell PV, Schoch G, Martin PJ, McFarland C, McCune JS, Cooper JP, Doney K, Flowers MED, Sorror ML, Appelbaum FR, Storer BE, Gooley T, Deeg HJ.
PMID: 34741096
Bone Marrow Transplant. 2021 Nov 05; doi: 10.1038/s41409-021-01518-0. Epub 2021 Nov 05.

We evaluated long-term outcome in 40 patients with MDS or AML, transplanted from related or unrelated donors following conditioning with targeted busulfan (Bu, over 4 days), fludarabine (Flu, 120 [n = 23] or 250 [n = 17] mg/m

Cite
Yeh AC, O'Donnell PV, Schoch G, et al. Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin. Bone Marrow Transplant. 2021;doi: 10.1038/s41409-021-01518-0.
Yeh, A. C., O'Donnell, P. V., Schoch, G., Martin, P. J., McFarland, C., McCune, J. S., Cooper, J. P., Doney, K., Flowers, M. E. D., Sorror, M. L., Appelbaum, F. R., Storer, B. E., Gooley, T., & Deeg, H. J. (2021). Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin. Bone marrow transplantation, . https://doi.org/10.1038/s41409-021-01518-0
Yeh, Albert C, et al. "Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin." Bone marrow transplantation vol. (2021). doi: https://doi.org/10.1038/s41409-021-01518-0
Yeh AC, O'Donnell PV, Schoch G, Martin PJ, McFarland C, McCune JS, Cooper JP, Doney K, Flowers MED, Sorror ML, Appelbaum FR, Storer BE, Gooley T, Deeg HJ. Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin. Bone Marrow Transplant. 2021 Nov 05; doi: 10.1038/s41409-021-01518-0. Epub 2021 Nov 05. PMID: 34741096.
Copy Download .nbib Format: NLM
Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation.

Blood advances

Li A, Davis C, Wu Q, Li S, Kesten MF, Holmberg LA, Gopal AK, Garcia DA.
PMID: 29296714
Blood Adv. 2017 Apr 27;1(12):707-714. doi: 10.1182/bloodadvances.2017006130. eCollection 2017 May 09.

Management of venous thromboembolism (VTE) remains challenging in patients with hematologic malignancy who undergo hematopoietic cell transplantation (HCT) due to prolonged thrombocytopenia. This study aims to (1) determine the incidence of VTE recurrence and bleeding during autologous HCT, (2)...

Cite
Li A, Davis C, Wu Q, et al. Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation. Blood Adv. 2017;1(12):707-714doi: 10.1182/bloodadvances.2017006130.
Li, A., Davis, C., Wu, Q., Li, S., Kesten, M. F., Holmberg, L. A., Gopal, A. K., & Garcia, D. A. (2017). Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation. Blood advances, 1(12), 707-714. https://doi.org/10.1182/bloodadvances.2017006130
Li, Ang, et al. "Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation." Blood advances vol. 1,12 (2017): 707-714. doi: https://doi.org/10.1182/bloodadvances.2017006130
Li A, Davis C, Wu Q, Li S, Kesten MF, Holmberg LA, Gopal AK, Garcia DA. Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation. Blood Adv. 2017 Apr 27;1(12):707-714. doi: 10.1182/bloodadvances.2017006130. eCollection 2017 May 09. PMID: 29296714; PMCID: PMC5728057.
Copy Download .nbib Format: NLM
The Diving Bell and the Butterfly Revisited: A Fatal Case of Locked-in Syndrome in a Man With Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.

Clinical medicine insights. Blood disorders

Poston JN, Dorer R, Aboulafia DM.
PMID: 29623003
Clin Med Insights Blood Disord. 2018 Mar 26;11:1179545X18762799. doi: 10.1177/1179545X18762799. eCollection 2018.

Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) is a rare variant of DLBCL. The natural history of this subtype is poorly understood. Incomplete literature in the era of rituximab suggests that patients with EBV-positive DLBCL have similar outcomes...

Cite
Poston JN, Dorer R, Aboulafia DM. The Diving Bell and the Butterfly Revisited: A Fatal Case of Locked-in Syndrome in a Man With Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified. Clin Med Insights Blood Disord. 2018;11:1179545X18762799doi: 10.1177/1179545X18762799.
Poston, J. N., Dorer, R., & Aboulafia, D. M. (2018). The Diving Bell and the Butterfly Revisited: A Fatal Case of Locked-in Syndrome in a Man With Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified. Clinical medicine insights. Blood disorders, 111179545X18762799. https://doi.org/10.1177/1179545X18762799
Poston, Jacqueline N, et al. "The Diving Bell and the Butterfly Revisited: A Fatal Case of Locked-in Syndrome in a Man With Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified." Clinical medicine insights. Blood disorders vol. 11 (2018): 1179545X18762799. doi: https://doi.org/10.1177/1179545X18762799
Poston JN, Dorer R, Aboulafia DM. The Diving Bell and the Butterfly Revisited: A Fatal Case of Locked-in Syndrome in a Man With Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified. Clin Med Insights Blood Disord. 2018 Mar 26;11:1179545X18762799. doi: 10.1177/1179545X18762799. eCollection 2018. PMID: 29623003; PMCID: PMC5881979.
Copy Download .nbib Format: NLM
Burkitt lymphoma of the maxilla in a HIV positive male - Presentation and review of diagnostic laboratory tests.

Oral and maxillofacial surgery cases

Alvarez W, Lai LH, Grant SJ, Sabath DE, Dillon J.
PMID: 33282691
Oral Maxillofac Surg Cases. 2019 Sep;5(3). doi: 10.1016/j.omsc.2019.100113. Epub 2019 Jul 03.

Burkitt lymphoma (BL) is a highly aggressive, B cell non-Hodgkin lymphoma (NHL) that is rare outside Africa. We report a case of HIV-associated BL originating in the right maxillary sinus in a 31-year-old Hispanic male living in Washington, USA....

Cite
Alvarez W, Lai LH, Grant SJ, et al. Burkitt lymphoma of the maxilla in a HIV positive male - Presentation and review of diagnostic laboratory tests. Oral Maxillofac Surg Cases. 2019;5(3)doi: 10.1016/j.omsc.2019.100113.
Alvarez, W., Lai, L. H., Grant, S. J., Sabath, D. E., & Dillon, J. (2019). Burkitt lymphoma of the maxilla in a HIV positive male - Presentation and review of diagnostic laboratory tests. Oral and maxillofacial surgery cases, 5(3), . https://doi.org/10.1016/j.omsc.2019.100113
Alvarez, William, et al. "Burkitt lymphoma of the maxilla in a HIV positive male - Presentation and review of diagnostic laboratory tests." Oral and maxillofacial surgery cases vol. 5,3 (2019). doi: https://doi.org/10.1016/j.omsc.2019.100113
Alvarez W, Lai LH, Grant SJ, Sabath DE, Dillon J. Burkitt lymphoma of the maxilla in a HIV positive male - Presentation and review of diagnostic laboratory tests. Oral Maxillofac Surg Cases. 2019 Sep;5(3). doi: 10.1016/j.omsc.2019.100113. Epub 2019 Jul 03. PMID: 33282691; PMCID: PMC7714209.
Copy Download .nbib Format: NLM
Acute Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Cooper JP, Perkins JD, Warner PR, Shingina A, Biggins SW, Abkowitz JL, Reyes JD.
PMID: 34587357
Liver Transpl. 2021 Sep 29; doi: 10.1002/lt.26318. Epub 2021 Sep 29.

Acute graft-versus-host disease (GVHD) is a rare complication after orthotopic liver transplantation (OLT) that carries high mortality. We hypothesized that machine-learning algorithms to predict rare events would identify patients at high risk for developing GVHD. To develop a predictive...

Cite
Cooper JP, Perkins JD, Warner PR, et al. Acute Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning. Liver Transpl. 2021;doi: 10.1002/lt.26318.
Cooper, J. P., Perkins, J. D., Warner, P. R., Shingina, A., Biggins, S. W., Abkowitz, J. L., & Reyes, J. D. (2021). Acute Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, . https://doi.org/10.1002/lt.26318
Cooper, Jason P, et al. "Acute Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning." Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society vol. (2021). doi: https://doi.org/10.1002/lt.26318
Cooper JP, Perkins JD, Warner PR, Shingina A, Biggins SW, Abkowitz JL, Reyes JD. Acute Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning. Liver Transpl. 2021 Sep 29; doi: 10.1002/lt.26318. Epub 2021 Sep 29. PMID: 34587357.
Copy Download .nbib Format: NLM
Acute Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Cooper JP, Perkins JD, Warner PR, Shingina A, Biggins SW, Abkowitz JL, Reyes JD.
PMID: 34587357
Liver Transpl. 2021 Sep 29; doi: 10.1002/lt.26318. Epub 2021 Sep 29.

Acute graft-versus-host disease (GVHD) is a rare complication after orthotopic liver transplantation (OLT) that carries high mortality. We hypothesized that machine-learning algorithms to predict rare events would identify patients at high risk for developing GVHD. To develop a predictive...

Cite
Cooper JP, Perkins JD, Warner PR, et al. Acute Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning. Liver Transpl. 2021;doi: 10.1002/lt.26318.
Cooper, J. P., Perkins, J. D., Warner, P. R., Shingina, A., Biggins, S. W., Abkowitz, J. L., & Reyes, J. D. (2021). Acute Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, . https://doi.org/10.1002/lt.26318
Cooper, Jason P, et al. "Acute Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning." Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society vol. (2021). doi: https://doi.org/10.1002/lt.26318
Cooper JP, Perkins JD, Warner PR, Shingina A, Biggins SW, Abkowitz JL, Reyes JD. Acute Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning. Liver Transpl. 2021 Sep 29; doi: 10.1002/lt.26318. Epub 2021 Sep 29. PMID: 34587357.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries